All News

A behavioral program that includes group meetings can help reduce pregnancy weight gain in obese women and the prevalence of large-for-gestational-age (LGA) infants, according to the results of a study supported by the National Institute of Child Health and Human Development. The findings, from a randomized clinical trial (RCT), were published in Obesity.

The US Preventive Services Task Force (USPSTF) has issued a new report supporting prophylaxis with low-dose aspirin (81 mg/d) after 12 weeks’ gestation in women at high risk of preeclampsia.

In this era of highly regulated medical training, most residency and fellowship programs establish rigorous educational objectives and procedural curricula for their trainees. Guided by the expectations set by ACOG and ABOG, Ob/Gyn training programs rely upon structured didactic sessions and guided reading recommendations to keep their residents in compliance with these benchmarks.

Improving patient-doctor communication is the goal of genitourinary syndrome of menopause (GSM), the new name for vaginal atrophy and other menopause symptoms.

Vaginal misoprostol applied prior to intrauterine device (IUD) insertion does not make the procedure go any easier or lessen the patient’s pain, a Dutch study shows. And because the drug has side-effects, the research team suggests it probably shouldn’t be used at all for this purpose. Video provided by The Doctor's Channel.

An analysis of data from 46 states and the District of Columbia shows that the level of Medicaid reimbursement for office visits has an impact on likelihood of patient screening with Pap tests and other diagnostics for cancer.

William Fredette, MD, discusses the benefits of Antiprogestin CDB-2914 for reducing uterine fibroid size and bleeding, and improving quality of life for affected women, as reported in the journal Fertility and Sterility. Video provided by The Doctor's Channel.

William Fredette, MD, discusses an updated practice guideline from the American Society of Clinical Oncology (published in the Journal of Clinical Oncology), where it calls on doctors caring for women at increased risk of breast cancer to discuss with them the risks and benefits of specific chemoprevention agents to lower their risk. Video provided by The Doctor's Channel and Reuters.